A detailed history of Groupama Asset Managment transactions in Bio Techne Corp stock. As of the latest transaction made, Groupama Asset Managment holds 3,566 shares of TECH stock, worth $254,184. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,566
Previous 3,485 2.32%
Holding current value
$254,184
Previous $250 Million 8.36%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$70.96 - $82.35 $5,747 - $6,670
81 Added 2.32%
3,566 $229 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $99,578 - $134,892
-1,603 Reduced 31.51%
3,485 $250 Million
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $458,758 - $536,006
-6,953 Reduced 57.74%
5,088 $756 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $636,126 - $941,847
12,041 New
12,041 $929 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.